Stella Pharma Corporation

Tokyo Stock Exchange 4888.T

Stella Pharma Corporation Cash and Short-Term Investments for the year ending March 31, 2024: USD 15.55 M

Stella Pharma Corporation Cash and Short-Term Investments is USD 15.55 M for the year ending March 31, 2024, a -23.77% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Stella Pharma Corporation Cash and Short-Term Investments for the year ending March 31, 2023 was USD 20.40 M, a -24.20% change year over year.
  • Stella Pharma Corporation Cash and Short-Term Investments for the year ending March 31, 2022 was USD 26.91 M, a 138.20% change year over year.
  • Stella Pharma Corporation Cash and Short-Term Investments for the year ending March 31, 2021 was USD 11.30 M, a -39.46% change year over year.
  • Stella Pharma Corporation Cash and Short-Term Investments for the year ending March 31, 2020 was USD 18.66 M.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
SV Wall Street
Tokyo Stock Exchange: 4888.T

Stella Pharma Corporation

CEO Mr. Koki Uehara
IPO Date April 22, 2021
Location Japan
Headquarters ORIX Kouraibashi Building
Employees 44
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

StockViz Staff

January 31, 2025

Any question? Send us an email